Clinical applicability considerations for depot-specific miRNA profiling in gastrointestinal cancer [0.03%]
胃肠癌症中针对缓释剂的特异性miRNA谱分析的临床适用性考虑因素
Xiuzhi Cao,Lu Li,Ming Zhuang
Xiuzhi Cao
Monica Rubio-Ardanaz,Miguel Sogbe,Juan Felipe Lucena
Monica Rubio-Ardanaz
Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension [0.03%]
联合治疗的新证据重申β受体阻滞剂在难治性高血压中的作用
Stefano Masi,Claudio Borghi
Stefano Masi
Hospital-to-community care pathways for patients with heart failure, an inter-society consensus document [0.03%]
心力衰竭患者从医院到社区的诊疗路径专家共识文件
Mario Mallardo,Pasquale Perrone Filardi,Claudio Micheletto et al.
Mario Mallardo et al.
Heart failure (HF) remains one of the most prevalent and burdensome chronic conditions worldwide, with rising incidence and poor prognosis despite major therapeutic advances. Effective management requires a comprehensive, multidisciplinary ...
Bedside-oriented new risk stratification in acute pulmonary embolism: Implications and clinical utility of the 2026 ACC/AHA guidelines compared with the 2019 ESC guidelines [0.03%]
以床旁为导向的急性肺栓塞新的风险分层：与2019年ESC指南相比，2026年ACC / AHA指南的意义和临床实用性
Yugo Yamashita,Takeshi Morimoto,Ryuki Chatani et al.
Yugo Yamashita et al.
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement [0.03%]
基层医疗中心心血管-肾脏-肝脏代谢综合征的评估与管理：多学科共识声明
Reinhold Kreutz,Ali Canbay,Martin Haluzik et al.
Reinhold Kreutz et al.
The recently introduced cardiovascular-kidney-metabolic (CKM) syndrome captures the close interplay between metabolic risk factors, chronic kidney disease, and cardiovascular disease, but insufficiently reflects the important additional rol...
Effects of urine uromodulin levels on the association between sodium intake and ambulatory blood pressure in individuals with chronic kidney disease [0.03%]
尿囊素水平对慢性肾脏病患者钠摄入量与动态血压关系的影响
Artemios G Karagiannidis,Amalia Baroutidou,Marieta Theodorakopoulou et al.
Artemios G Karagiannidis et al.
Background: In CKD, hypertension is often accompanied by sodium sensitivity. Uromodulin promotes sodium sensitivity by activating tubular sodium transporters (NKCC2, NCC). In the general population, individuals with highe...